nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Parkinson's disease	0.897	1	CbGaD
Ticagrelor—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.00431	0.0433	CbGpPWpGaD
Ticagrelor—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00252	0.0254	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—DGKQ—Parkinson's disease	0.00209	0.021	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00184	0.0186	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00158	0.0159	CbGpPWpGaD
Ticagrelor—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00155	0.0156	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00135	0.0136	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—PENK—Parkinson's disease	0.00128	0.0129	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MERTK—Parkinson's disease	0.00121	0.0121	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—DOCK3—Parkinson's disease	0.00121	0.0121	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GPR37—Parkinson's disease	0.0012	0.0121	CbGpPWpGaD
Ticagrelor—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0012	0.0121	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00117	0.0118	CbGpPWpGaD
Ticagrelor—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00111	0.0112	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—DGKQ—Parkinson's disease	0.00108	0.0108	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00102	0.0102	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000931	0.00937	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000892	0.00898	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000859	0.00865	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.000848	0.00854	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GRM4—Parkinson's disease	0.000818	0.00823	CbGpPWpGaD
Ticagrelor—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000816	0.00821	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000803	0.00809	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000783	0.00789	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—PENK—Parkinson's disease	0.000775	0.0078	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000751	0.00756	CbGpPWpGaD
Ticagrelor—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000746	0.00751	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000745	0.0075	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000736	0.00741	CbGpPWpGaD
Ticagrelor—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000734	0.00739	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000724	0.00729	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00072	0.00725	CbGpPWpGaD
Ticagrelor—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000718	0.00722	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—PDYN—Parkinson's disease	0.000709	0.00714	CbGpPWpGaD
Ticagrelor—P2RY12—forebrain—Parkinson's disease	0.000699	0.199	CbGeAlD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000697	0.00702	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAG—Parkinson's disease	0.000693	0.00698	CbGpPWpGaD
Ticagrelor—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000682	0.00687	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00068	0.00684	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000679	0.00684	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000666	0.0067	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GRM5—Parkinson's disease	0.000659	0.00664	CbGpPWpGaD
Ticagrelor—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000656	0.00661	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000639	0.00643	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00063	0.00635	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00063	0.00635	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.00063	0.00634	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000629	0.00633	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000626	0.0063	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GPR37—Parkinson's disease	0.000617	0.00621	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DGKQ—Parkinson's disease	0.000617	0.00621	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000617	0.00621	CbGpPWpGaD
Ticagrelor—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000615	0.00619	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000613	0.00617	CbGpPWpGaD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000607	0.00611	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000598	0.00602	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000597	0.00601	CbGpPWpGaD
Ticagrelor—P2RY12—cardiovascular system—Parkinson's disease	0.000591	0.169	CbGeAlD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000583	0.00587	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000565	0.00569	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000565	0.00568	CbGpPWpGaD
Ticagrelor—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000563	0.00566	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00056	0.00564	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000554	0.00558	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00054	0.00544	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00054	0.00544	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000516	0.00519	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GRK5—Parkinson's disease	0.000515	0.00519	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR1A—Parkinson's disease	0.000486	0.0049	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—TAC1—Parkinson's disease	0.000479	0.00482	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD1—Parkinson's disease	0.00047	0.00473	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GRK5—Parkinson's disease	0.000468	0.00471	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GRM4—Parkinson's disease	0.000462	0.00465	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD3—Parkinson's disease	0.000455	0.00458	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000446	0.00449	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000442	0.00445	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VPS35—Parkinson's disease	0.00044	0.00443	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PENK—Parkinson's disease	0.000438	0.00441	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—FGB—Parkinson's disease	0.000437	0.0044	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000436	0.00439	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000432	0.00435	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GRM4—Parkinson's disease	0.00042	0.00422	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR7—Parkinson's disease	0.000411	0.00414	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—DRD2—Parkinson's disease	0.000411	0.00414	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PDYN—Parkinson's disease	0.000401	0.00403	CbGpPWpGaD
Ticagrelor—P2RY12—head—Parkinson's disease	0.0004	0.114	CbGeAlD
Ticagrelor—P2RY12—Signaling by GPCR—PENK—Parkinson's disease	0.000398	0.004	CbGpPWpGaD
Ticagrelor—P2RY12—nervous system—Parkinson's disease	0.000379	0.108	CbGeAlD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000378	0.00381	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GRM5—Parkinson's disease	0.000372	0.00375	CbGpPWpGaD
Ticagrelor—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000366	0.00368	CbGpPWpGaD
Ticagrelor—P2RY12—central nervous system—Parkinson's disease	0.000365	0.104	CbGeAlD
Ticagrelor—P2RY12—Signaling Pathways—DGKQ—Parkinson's disease	0.000365	0.00367	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GPR37—Parkinson's disease	0.000365	0.00367	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PDYN—Parkinson's disease	0.000364	0.00366	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00035	0.00353	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000348	0.00351	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000347	0.00349	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GRM5—Parkinson's disease	0.000338	0.00341	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000338	0.0034	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000334	0.00336	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—EDN1—Parkinson's disease	0.000329	0.00332	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000327	0.00329	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SOD1—Parkinson's disease	0.000325	0.00327	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000317	0.00319	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00031	0.00312	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ABL1—Parkinson's disease	0.00031	0.00312	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IGF2—Parkinson's disease	0.000308	0.0031	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000306	0.00308	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000293	0.00295	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RIT2—Parkinson's disease	0.000292	0.00293	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—HGF—Parkinson's disease	0.000291	0.00293	CbGpPWpGaD
Ticagrelor—P2RY12—brain—Parkinson's disease	0.00029	0.0827	CbGeAlD
Ticagrelor—P2RY12—GPCR ligand binding—HTR2A—Parkinson's disease	0.000288	0.0029	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000288	0.0029	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000283	0.00285	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00028	0.00282	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GRK5—Parkinson's disease	0.000276	0.00278	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000275	0.00277	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—TAC1—Parkinson's disease	0.000271	0.00272	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD1—Parkinson's disease	0.000265	0.00267	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.00026	0.00262	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD3—Parkinson's disease	0.000257	0.00259	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000251	0.00253	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR1A—Parkinson's disease	0.00025	0.00251	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GRM4—Parkinson's disease	0.000248	0.0025	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—TAC1—Parkinson's disease	0.000246	0.00247	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000243	0.00245	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD1—Parkinson's disease	0.000241	0.00243	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00024	0.00242	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PENK—Parkinson's disease	0.000235	0.00237	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAG—Parkinson's disease	0.000235	0.00237	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD3—Parkinson's disease	0.000233	0.00235	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—DRD2—Parkinson's disease	0.000232	0.00234	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR7—Parkinson's disease	0.000232	0.00234	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00023	0.00231	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000218	0.00219	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDYN—Parkinson's disease	0.000215	0.00216	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—DRD2—Parkinson's disease	0.000211	0.00213	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR7—Parkinson's disease	0.000211	0.00213	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000203	0.00204	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000203	0.00204	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GFAP—Parkinson's disease	0.000202	0.00203	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000201	0.00203	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GRM5—Parkinson's disease	0.0002	0.00201	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000199	0.002	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000189	0.0019	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—EDN1—Parkinson's disease	0.000186	0.00187	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00018	0.00181	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF20—Parkinson's disease	0.000175	0.00176	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADORA2A—Parkinson's disease	0.00017	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EDN1—Parkinson's disease	0.000169	0.0017	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000163	0.00164	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INSR—Parkinson's disease	0.000157	0.00158	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGB—Parkinson's disease	0.000148	0.00149	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR2A—Parkinson's disease	0.000148	0.00149	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR1A—Parkinson's disease	0.000147	0.00148	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000147	0.00148	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000147	0.00148	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000146	0.00147	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TAC1—Parkinson's disease	0.000145	0.00146	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000145	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD1—Parkinson's disease	0.000142	0.00143	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD3—Parkinson's disease	0.000138	0.00139	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000133	0.00134	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000132	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRBK1—Parkinson's disease	0.000129	0.0013	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000128	0.00129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DRD2—Parkinson's disease	0.000125	0.00126	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR7—Parkinson's disease	0.000125	0.00126	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000122	0.00123	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00012	0.00121	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000107	0.00108	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—Parkinson's disease	0.000106	0.00107	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MCCC1—Parkinson's disease	0.000106	0.00107	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ND3—Parkinson's disease	0.000106	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF2—Parkinson's disease	0.000105	0.00105	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000101	0.00102	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1R—Parkinson's disease	0.000101	0.00102	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000101	0.00101	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.0001	0.00101	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TALDO1—Parkinson's disease	0.0001	0.00101	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—OMD—Parkinson's disease	0.0001	0.00101	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDN1—Parkinson's disease	9.98e-05	0.00101	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	9.97e-05	0.001	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	9.92e-05	0.000999	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.89e-05	0.000996	CbGpPWpGaD
Ticagrelor—ABCB1—embryo—Parkinson's disease	9.72e-05	0.0277	CbGeAlD
Ticagrelor—ABCB1—Metabolism—NDUFB11—Parkinson's disease	9.49e-05	0.000955	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	9.25e-05	0.000931	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NGF—Parkinson's disease	9.17e-05	0.000924	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	9.12e-05	0.000918	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCH1—Parkinson's disease	9.05e-05	0.000911	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HTR2A—Parkinson's disease	8.73e-05	0.000879	CbGpPWpGaD
Ticagrelor—ABCB1—forebrain—Parkinson's disease	8.6e-05	0.0245	CbGeAlD
Ticagrelor—P2RY12—Signaling Pathways—APOE—Parkinson's disease	8.12e-05	0.000817	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DBH—Parkinson's disease	8.07e-05	0.000812	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GBA—Parkinson's disease	8.07e-05	0.000812	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FBP1—Parkinson's disease	8.07e-05	0.000812	CbGpPWpGaD
Ticagrelor—ABCB1—cardiovascular system—Parkinson's disease	7.27e-05	0.0207	CbGeAlD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	7.22e-05	0.000727	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.05e-05	0.000709	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INS—Parkinson's disease	6.94e-05	0.000698	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.77e-05	0.000681	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	6.64e-05	0.000668	CbGpPWpGaD
Ticagrelor—CYP3A4—nervous system—Parkinson's disease	6.6e-05	0.0188	CbGeAlD
Ticagrelor—CYP3A4—Metabolism—MCCC1—Parkinson's disease	6.56e-05	0.00066	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ND3—Parkinson's disease	6.56e-05	0.00066	CbGpPWpGaD
Ticagrelor—CYP3A4—central nervous system—Parkinson's disease	6.35e-05	0.0181	CbGeAlD
Ticagrelor—ABCB1—medulla oblongata—Parkinson's disease	6.21e-05	0.0177	CbGeAlD
Ticagrelor—CYP3A4—Metabolism—OMD—Parkinson's disease	6.16e-05	0.000621	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TALDO1—Parkinson's disease	6.16e-05	0.000621	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DDC—Parkinson's disease	5.92e-05	0.000596	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.88e-05	0.000592	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	5.84e-05	0.000588	CbGpPWpGaD
Ticagrelor—ABCB1—midbrain—Parkinson's disease	5.68e-05	0.0162	CbGeAlD
Ticagrelor—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.59e-05	0.000563	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCH1—Parkinson's disease	5.58e-05	0.000561	CbGpPWpGaD
Ticagrelor—ABCB1—spinal cord—Parkinson's disease	5.54e-05	0.0158	CbGeAlD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	5.25e-05	0.000529	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—Parkinson's disease	5.16e-05	0.00052	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—Parkinson's disease	5.13e-05	0.000517	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G6—Parkinson's disease	5.03e-05	0.000507	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MAOB—Parkinson's disease	4.98e-05	0.000502	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DBH—Parkinson's disease	4.97e-05	0.0005	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.97e-05	0.0005	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GBA—Parkinson's disease	4.97e-05	0.0005	CbGpPWpGaD
Ticagrelor—ABCB1—head—Parkinson's disease	4.92e-05	0.014	CbGeAlD
Ticagrelor—P2RY12—Signaling Pathways—MAPK8—Parkinson's disease	4.75e-05	0.000478	CbGpPWpGaD
Ticagrelor—ABCB1—nervous system—Parkinson's disease	4.67e-05	0.0133	CbGeAlD
Ticagrelor—ABCB1—central nervous system—Parkinson's disease	4.5e-05	0.0128	CbGeAlD
Ticagrelor—ABCB1—cerebellum—Parkinson's disease	4.39e-05	0.0125	CbGeAlD
Ticagrelor—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.7e-05	0.000373	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DDC—Parkinson's disease	3.65e-05	0.000367	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CTGF—Parkinson's disease	3.63e-05	0.000366	CbGpPWpGaD
Ticagrelor—ABCB1—brain—Parkinson's disease	3.57e-05	0.0102	CbGeAlD
Ticagrelor—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.44e-05	0.000347	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.39e-05	0.000341	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NQO1—Parkinson's disease	3.35e-05	0.000337	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TH—Parkinson's disease	3.3e-05	0.000332	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYCS—Parkinson's disease	3.17e-05	0.000319	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.1e-05	0.000312	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.07e-05	0.000309	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—Parkinson's disease	3.03e-05	0.000305	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COMT—Parkinson's disease	2.81e-05	0.000283	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.79e-05	0.000281	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MAOA—Parkinson's disease	2.79e-05	0.000281	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.75e-05	0.000277	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.57e-05	0.000258	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX1—Parkinson's disease	2.46e-05	0.000247	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.28e-05	0.00023	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.27e-05	0.000228	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.24e-05	0.000225	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOE—Parkinson's disease	2.11e-05	0.000213	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.09e-05	0.00021	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.06e-05	0.000208	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TH—Parkinson's disease	2.03e-05	0.000205	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.95e-05	0.000197	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—INS—Parkinson's disease	1.8e-05	0.000182	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COMT—Parkinson's disease	1.73e-05	0.000174	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.72e-05	0.000173	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.72e-05	0.000173	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.7e-05	0.000171	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.63e-05	0.000164	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.58e-05	0.000159	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.51e-05	0.000152	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.4e-05	0.000141	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOE—Parkinson's disease	1.3e-05	0.000131	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—INS—Parkinson's disease	1.11e-05	0.000112	CbGpPWpGaD
